These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators. Bollmann A; Husser D; Cannom DS Am J Cardiovasc Drugs; 2005; 5(6):371-8. PubMed ID: 16259525 [TBL] [Abstract][Full Text] [Related]
3. Intradevice interaction in a dual chamber implantable cardioverter defibrillator preventing ventricular tachyarrhythmia detection. Shivkumar K; Feliciano Z; Boyle NG; Wiener I J Cardiovasc Electrophysiol; 2000 Nov; 11(11):1285-8. PubMed ID: 11083251 [TBL] [Abstract][Full Text] [Related]
4. Limitations and late complications of third-generation automatic cardioverter-defibrillators. Nunain SO; Roelke M; Trouton T; Osswald S; Kim YH; Sosa-Suarez G; Brooks DR; McGovern B; Guy M; Torchiana DF Circulation; 1995 Apr; 91(8):2204-13. PubMed ID: 7697850 [TBL] [Abstract][Full Text] [Related]
5. Advanced ICD troubleshooting: Part I. Swerdlow CD; Friedman PA Pacing Clin Electrophysiol; 2005 Dec; 28(12):1322-46. PubMed ID: 16403166 [No Abstract] [Full Text] [Related]
6. Antiarrhythmic drug use in the implantable defibrillator arm of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Study. Steinberg JS; Martins J; Sadanandan S; Goldner B; Menchavez E; Domanski M; Russo A; Tullo N; Hallstrom A; Am Heart J; 2001 Sep; 142(3):520-9. PubMed ID: 11526368 [TBL] [Abstract][Full Text] [Related]
7. Implantable cardioverter defibrillator therapy and the need for concomitant antiarrhythmic drugs. Singh S; Murawski MM J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):175-80. PubMed ID: 17875944 [TBL] [Abstract][Full Text] [Related]
8. ICD-antiarrhythmic drug and ICD-pacemaker interactions. Brode SE; Schwartzman D; Callans DJ; Gottlieb CD; Marchlinski FE J Cardiovasc Electrophysiol; 1997 Jul; 8(7):830-42. PubMed ID: 9255691 [TBL] [Abstract][Full Text] [Related]
9. Sudden Death in Patients With Cardiac Implantable Electronic Devices. Tseng ZH; Hayward RM; Clark NM; Mulvanny CG; Colburn BJ; Ursell PC; Olgin JE; Hart AP; Moffatt E JAMA Intern Med; 2015 Aug; 175(8):1342-50. PubMed ID: 26098676 [TBL] [Abstract][Full Text] [Related]
16. A comparison of the AVID and DAVID trials of implantable defibrillators. Sharma A; Epstein AE; Herre JM; Klein RC; Platia EV; Wilkoff B; Ledingham RB; Greene HL; Hallstrom AP; Am J Cardiol; 2005 Jun; 95(12):1431-5. PubMed ID: 15950565 [TBL] [Abstract][Full Text] [Related]
17. Ventricular tachycardia or ventricular fibrillation occurs less often in patients with left bundle branch block and combined resynchronization and defibrillators than in patients with narrow QRS and conventional defibrillators. Blaschke F; Knaus T; Celebi O; Krebs A; Nitardy A; Habedank D; Dietz R; Stockburger M Europace; 2012 Feb; 14(2):224-9. PubMed ID: 21946820 [TBL] [Abstract][Full Text] [Related]
18. Role of antiarrhythmic therapy in patients at risk for sudden cardiac death: an evidence-based review. Hilleman DE; Bauman AL Pharmacotherapy; 2001 May; 21(5):556-75. PubMed ID: 11349745 [TBL] [Abstract][Full Text] [Related]